🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Tandem Diabetes Care Inc (TNDM)

NASDAQ
Currency in USD
31.10
-0.27(-0.86%)
Closed
After Hours
30.65-0.45(-1.45%)
TNDM Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
30.2831.76
52 wk Range
17.3353.69
Prev. Close
31.1
Open
30.75
Day's Range
30.28-31.76
52 wk Range
17.33-53.69
Volume
1,311,466
Average Vol. (3m)
1,272,192
1-Year Change
107.61%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
TNDM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
51.30
Upside
+64.95%
Members' Sentiments
Bearish
Bullish
ProTips
9 analysts have revised their earnings downwards for the upcoming period
Show more

Tandem Diabetes Care Inc Company Profile

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

InvestingPro Research for Tandem Diabetes Care Inc


Growth Opportunities
Learn about Tandem's potential expansion into the Type 2 diabetes market, which could significantly increase its addressable market and drive long-term growth
Competitive Pressures
Delve into Tandem's struggle to maintain market share amid fierce competition, with flat year-over-year new patient starts raising concerns
Financial Outlook
Analysts project near-term challenges with negative EPS, but see potential for upward revisions. Price targets range from $58 to $65, signaling optimism
Mobi's Market Impact
Explore how Tandem's Mobi insulin pump system is driving growth and outperforming expectations, positioning the company for potential market expansion
Read full SWOT analysis

Compare TNDM to Peers and Sector

Metrics to compare
TNDM
Peers
Sector
Relationship
P/E Ratio
−16.1x−5.3x−0.7x
PEG Ratio
−0.410.100.00
Price / Book
8.6x2.1x2.6x
Price / LTM Sales
2.4x1.5x3.2x
Upside (Analyst Target)
76.9%30.5%45.2%
Fair Value Upside
Unlock−0.9%7.0%Unlock

People Also Watch

18.67
ACMR
-2.20%
55.37
RMBS
-0.93%
343.86
POWL
-2.42%
22.85
OPCH
-0.04%
23.040
CPRX
-1.75%

FAQ

What Is the Tandem Diabetes Care (TNDM) Stock Price Today?

The Tandem Diabetes Care stock price today is 31.10

What Stock Exchange Does Tandem Diabetes Care Trade On?

Tandem Diabetes Care is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Tandem Diabetes Care?

The stock symbol for Tandem Diabetes Care is "TNDM."

What Is the Tandem Diabetes Care Market Cap?

As of today, Tandem Diabetes Care market cap is 2.04B.

What is Tandem Diabetes Care Earnings Per Share?

The Tandem Diabetes Care EPS is -1.94.

What Is the Next Tandem Diabetes Care Earnings Date?

Tandem Diabetes Care will release its next earnings report on Feb 19, 2025.

From a Technical Analysis Perspective, Is TNDM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.